Trilaciclib is a first-of-its-kind prescription medicine that protects against the damage caused to bone marrow cells during chemotherapy. Since bone marrow cells form red and white blood cells, trilaciclib helps patients undergoing chemotherapy by reducing the side effects that
...
More than ever, there are more cancer treatments than just chemo. The current treatments for lung cancer are: surgery, radiation, chemotherapy, targeted treatments immunotherapy, and combination therapy. Working with your thoracic oncologist, a personalized approach can be created based
...
Small cell lung cancer (SCLC) is a rare and aggressive form of lung cancer. Several factors make it challenging to treat with long-term success. Screening is uncommon. The cancer is often in an advanced stage by the time it
...
28-Year-Old Faces Small Cell Lung Cancer Diagnosis Back in 2006, special education teacher Montessa Lee didn’t think too much about the intermittent pain she was experiencing in her chest. It wasn’t until her cousin insisted, in fact, that she
...
Lung cancer is the number one cancer killer worldwide. Of the 220,000 new cases diagnosed each year, Small Cell Lung Cancer (SCLC) accounts for 15% of cases. As an aggressive form of lung cancer, better therapies are needed desperately.
...
Funding supports search for new treatments for the deadliest form of cancer LOS ANGELES, Feb. 7, 2018 /PRNewswire/ – Groundbreaking research into the early diagnosis of lung cancer and potential new treatments have been awarded funding through two lung…